Related Experiment Video
Updated: Aug 9, 2025
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.3K
Implementing pragmatic clinical trials in hepatology
Elliot B Tapper1, Marina Serper2, David S Goldberg3
1Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
Hepatology (Baltimore, Md.)
|February 24, 2023
Summary
Pragmatic trial designs can improve clinical decision-making for chronic liver disease patients. These trials assess interventions in real-world settings, focusing on efficiency, usual care, and patient-important outcomes.
Area of Science:
- Hepatology and Clinical Trial Design
- Evidence-Based Medicine
- Translational Research
Background:
- Chronic liver disease management requires evidence applicable to real-world clinical practice.
- Traditional trial designs may not fully reflect the complexities of routine patient care.
- Bridging the gap between research findings and clinical adoption is crucial.
Approach:
- Reviewing the principles and application of pragmatic clinical trials in hepatology.
- Analyzing the efficiency of patient identification, recruitment, and follow-up in pragmatic designs.
- Evaluating the alignment of pragmatic trial interventions and protocols with standard clinical care.
Key Points:
- Pragmatic trials prioritize real-world applicability and patient relevance.
- Trial design elements include efficiency, mirroring usual care, and patient-centered outcomes.
- Understanding trade-offs is essential for effective pragmatic trial implementation.
Conclusions:
- Pragmatic trials offer a valuable framework for advancing care in chronic liver disease.
- These trials enhance the translation of research into improved clinical decision-making.
- Further exploration of pragmatic trial methodologies in hepatology is warranted.
More Related Videos
Related Concept Videos
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:11Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
68
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
68
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
155
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
155
01:26Drug Administration and Therapy Phases: Overview
608
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
608